|
|
|
Volumn 60, Issue 3, 2006, Pages 179-181
|
|
Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
INSULIN;
ROSIGLITAZONE;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HUMAN;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
BLOOD GLUCOSE;
BLOOD PRESSURE;
DIABETES MELLITUS, TYPE 2;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MIDDLE AGED;
THIAZOLIDINEDIONES;
|
|
EID: 33745417074
PISSN: 0350199X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
